The Investor Newsletter Daily

Novartis announced late Monday that the U.S. Food and Drug Administration (FDA) approved its Itvisma for certain forms of spinal muscular atrophy (SMA). The

Worried that the tech-stock sell-off in recent days is the beginning of the end for the AI boom? Don’t be, says Neuberger Berman’s Raheel

What Happened? Shares of online advertising giant Alphabet (NASDAQ:GOOGL) jumped 4.5% in the afternoon session after investor enthusiasm surged over its new Gemini 3

The broader market has surged to record highs in 2025, with the S&P 500 up about 14% year-to-date. Yet this rising tide has left

A lawsuit claims the cryptocurrency exchange turned a blind eye as $1 billion used to finance the Oct. 7 attacks in Israel and other

McGraw Hill MH vaulted nearly 5% and reached a record high on the stock market today. The education materials stock broke out of a

Coinbase Global Inc (NASDAQ: COIN) shares are trading lower Tuesday shares amid a drop in Bitcoin (CRYPTO: BTC). The move follows Argus Research downgrading

If you’ve been meaning to get involved in the stock market but weren’t sure where to start, Sterling Stock Picker makes the investing process

The Dow Jones recovered 800 points from the lows of the session to end with gains of 650 points. The index has now rallied

The major indexes broke above their 50-day moving averages, despite Nvidia and AMD woes. Here’s what to do now.